dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.

Axitinib: prices and alternatives

Axitinib is a selective VEGFR-1, VEGFR-2, and VEGFR-3 inhibitor indicated for advanced renal cell carcinoma (RCC): as first-line therapy in combination with avelumab or pembrolizumab, or as a single agent following failure of one prior systemic therapy.

2 products with this active ingredient from 1 manufacturer. Official prices from 12603 to 45480 EGP.

Every box with this active ingredient, cheapest first.

Inlyta 1 mg 56 f.c. tabsInlyta 1 mg 56 f.c. tabsانليتا 1مجم 56 قرصaxitinib · PfizerOfficial public price12603EGP
Inlyta 5mg 56 f.c. tabletsInlyta 5mg 56 f.c. tabletsانليتا 5مجم 56 قرصaxitinib · PfizerOfficial public price45480EGP

Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.